Trinity Biotech (TRIB) Short-term Investments (2017 - 2025)

Trinity Biotech (TRIB) posted Short-term Investments of $2.8 million for Q2 2025, up 12.55% sequentially from $2.5 million in Q4 2024.

Trinity Biotech (TRIB) Short-term Investments (2017 - 2025) Analysis & Trends

Trinity Biotech has reported Short-term Investments for 6 years, with the latest figure at $2.8 million in Q2 2025.

Quarterly Short-term Investments changed N/A year-over-year to $2.8 million in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $2.8 million (changed N/A YoY) and the FY2024 annual result came in at $2.5 million, up 1127.5% from the prior year.
Short-term Investments rose to $2.8 million in Q2 2025 per TRIB's latest filing, from $2.5 million in the prior quarter.
Over five years, Short-term Investments peaked at $2.8 million in Q2 2025 and troughed at $100000.0 in Q4 2022.
A 4-year average of $1.4 million and a median of $1.3 million in 2023 frame the typical range for Short-term Investments.
The sharpest annual moves came in 2023 and 2024: Short-term Investments jumped 100.0% in 2023, then soared 1127.5% in 2024.
Over 4 years, Short-term Investments stood at $100000.0 in 2022, then surged by 100.0% to $200000.0 in 2023, then jumped by 1127.5% to $2.5 million in 2024, then grew by 12.55% to $2.8 million in 2025.
According to Business Quant data, Short-term Investments over the past three periods registered $2.8 million, $2.5 million, and $200000.0 for Q2 2025, Q4 2024, and Q4 2023 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	198.70 Bn	193.10 Bn	7.27 Bn
2	Stryker	125.85 Bn	122.37 Bn	4.50 Bn
3	Medtronic	118.44 Bn	109.22 Bn	6.41 Bn
4	Boston Scientific	72.64 Bn	72.10 Bn	3.85 Bn
5	Edwards Lifesciences	51.94 Bn	47.69 Bn	1.35 Bn
6	Dexcom	34.48 Bn	32.53 Bn	830.00 Mn
7	GE HealthCare Technologies	33.60 Bn	31.49 Bn	2.18 Bn
8	Koninklijke Philips	26.30 Bn	22.98 Bn	4.55 Bn
9	Steris	23.00 Bn	22.52 Bn	684.20 Mn
10	Trinity Biotech	6.53 Mn	1.39 Mn	-

Download Data